pfizer

The single-dose RSV vaccine developed by Pfizer is administered to expectant mothers in the late second-to-third trimester of their pregnancy.

A new study suggests vaccinating pregnant women protects their newborns from the common but scary respiratory virus called RSV.

Pfizer is asking the Food and Drug Administration to expand use of its updated COVID-19 booster shot to children ages 5 to 11.

The patent infringement lawsuits were filed in the U.S. District Court for the District of Massachusetts and the Regional Court of Düsseldorf in Germany, according to a news release.

Moderna sued Pfizer and its German partner BioNTech on Friday, alleging that the two companies copied Moderna’s technology in developing their COVID-19 vaccine Comirnaty. Moderna said in a news release that Pfizer and BioNTech infringed on patents filed between 2010 and 2016 covering its mRNA technology, which Moderna used to develop its own COVID-19 vaccine, Spikevax.

The findings reflect the changing nature of the pandemic, in which the vast majority of people already have some protection against the virus due to vaccination or prior infection.

Pfizer has asked U.S. regulators to authorize its combination COVID-19 vaccine that adds protection against the newest omicron strains: the BA.4 and BA.5 variants.

Now entering late-stage clinical trials, the vaccine could be approved as soon as 2025.

The Pfizer pill, Paxlovid, is intended for people with COVID-19 who are more likely to become seriously ill. Previously only doctors could prescribe the drug

Pfizer says tweaking its COVID-19 vaccine to better target the omicron variant is safe and boosts protection.

The federal government is expected to authorize COVID-19 vaccinations for kids as young as 6 months old this weekend, with the CDC go-ahead vote Saturday the last hurdle to clear before doses can start being administered to babies across the U.S. The final decision will rest with CDC Director Dr. Rochelle Walensky, but she is expected to align with her…

The FDA authorized the first COVID-19 vaccination for children as young as six months on Friday. A panel of CDC advisors will vote Saturday, meaning shots for infants and preschoolers could be available as early as next week.

The FDA must still decide whether to take the recommendations and approve the COVID-19 vaccine for kids between six months and 5 years old.

COVID-19 shots for U.S. infants, toddlers and preschoolers moved a step closer Wednesday.

The White House has announced more steps to make the antiviral treatment Paxlovid more accessible across the U.S. as it projects COVID-19 infections will continue to spread over the summer travel season. The nation’s first federally backed test-to-treat site is opening Thursday in Rhode Island. The site will provide patients with immediate access to the drug once they test positive....

Pfizer says it will provide nearly two dozen products at not-for-profit prices in some of the world’s poorest countries. That includes its top-selling COVID-19 vaccine and treatment. The pharmaceutical giant said early Wednesday that it is launching a program aimed at improving health equity in 45 lower-income countries. Most of those nations are in Africa. The drugmaker aims to provide...

Pfizer says it will seek emergency use authorization for a three-dose course of its COVID-19 vaccine in pediatric patients ages 6 months to 5 years old after publishing data from it’s latest study.

The 18 million kids under 5 are the only group in the U.S. not yet eligible for COVID-19 vaccination.

The center’s director, Dr. Rochelle Walensky, adopted a panel’s recommendation Thursday.

New York City COVID infections have been on the rise once again in recent weeks, and while there’s no corresponding increase in severity, the health commissioner is reminding the public and providers that antiviral pills are effective treatments, too. Paxlovid, specifically, can reduce the risk of hospitalization and death by up to 88% when taken within five days of symptoms…